Downregulation of CSN6 attenuates papillary thyroid carcinoma progression by reducing Wnt/β‐catenin signaling and sensitizes cancer cells to FH535 therapy

Publisher: John Wiley & Sons Inc

E-ISSN: 2045-7634|7|2|285-296

ISSN: 2045-7634

Source: Cancer Medicine, Vol.7, Iss.2, 2018-02, pp. : 285-296

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract